Global Insight Services have recently published a report on Pulmonary Arterial Hypertension (PAH) Pipeline landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Pulmonary Arterial Hypertension (PAH) is a rare, progressive type of pulmonary hypertension characterized by thickening and narrowing of small pulmonary arteries which blocks the blood flow through the lungs which raises the blood pressure in the lungs.
The most common causes of Pulmonary Arterial Hypertension are mutations in the BMPR2 gene, underlying disease conditions such as systemic scleroderma, lupus erythematosus, critical congenital heart disease, or Down syndrome, blood clots in the lungs, injury to the cells that line the blood vessels of the lung.
The most common symptoms of Pulmonary Arterial Hypertension include shortness of breath (dyspnea), difficulty in exercising, dizziness, chest pain, fatigue, fainting episodes, swelling (edema) of the ankles or legs and a rapid heart rate.
Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31249
Global Insight Service’s, Pulmonary Arterial Hypertension (PAH) – Drug Pipeline Landscape, 2023 report provides an overview of the Pulmonary Arterial Hypertension (PAH) pipeline drugs. This report covers detailed insights on Pulmonary Arterial Hypertension (PAH) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Pulmonary Arterial Hypertension (PAH) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Ask For Customization: https://www.globalinsightservices.com/request-customization/GIS31249
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Some of the key players involved in development of Pulmonary Arterial Hypertension (PAH) therapeutics are :
- Aadi Bioscience, Inc.
- Aeon Respire Inc
- Aerami Therapeutics
- Aerovate Therapeutics
- AI Therapeutics
- Altavant Sciences GmbH
- Antlia Bioscience Inc
- APT Therapeutics Inc
- Aqualung Therapeutics Corp
- ATXA Therapeutics
- Assessment by Stage of Development
- Assessment by Companies
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Molecule Type
- Assessment by Route of Administration
Buy this report: https://www.globalinsightservices.com/inquiry-before-buying/GIS31249
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958